CAS No. |
34184-77-5 |
中文名称 |
(8S,13S,14S,17S)-13,17-二甲基-17-丙酰基-1,2,6,7,8,11,12,13,14,15,16,17-十二氢-3H-环戊烷并[a]菲-3-酮 |
英文名称 |
(8S,13S,14S,17S)-13,17-dimethyl-17-propionyl-1,2,6,7,8,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one |
别名 |
Promegestona | Estra-4,9-dien-3-one, 17-alpha-methyl-17-propionyl- | Promegestone (INN) | (8S,13S,14S,17S)-13,17-dimethyl-17-propanoyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one | Promegestone [INN] | Promegestone | PROMEGESTONE [MI] |
标准英文名 |
(8S,13S,14S,17S)-13,17-dimethyl-17-propionyl-1,2,6,7,8,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one |
分子式 |
C22H30O2 |
分子量 |
326.48
|
精确分子量 |
326.22
|
SMILES |
CCC(=O)[C@@]1(C)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3CC[C@@]21C |
标准SMILES |
CCC(=O)[C@@]1(C)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3CC[C@]12C |
用途 |
Promegestone is used for the treatment of menstrual irregularities due to ovulatory disorders, dysmenorrhea, premenstrual discomfort, mastalgia, abnormal uterine bleeding (e.g., associated with uterine fibroids), menopausal symptoms, and as adjunctive therapy during estrogen replacement therapy in menopause; it is also clinically indicated for conditions resulting from luteal phase deficiency, such as menstrual disorders, dysmenorrhea, endometriosis, premenstrual syndrome, and mastodynia. |
InChIKey |
QFFCYTLOTYIJMR-XMGTWHOFSA-N |